• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

drug costs

A gavel in the foreground with the scale of justice in the background
Pharma

PhRMA's Medicare price negotiation appeal sputters out

In the latest in a string of setbacks in the fight against Medicare drug price negotiations, a lawsuit from PhRMA has been rejected in appeals.
Fraiser Kansteiner Aug 27, 2026 10:42am
Donald Trump

Trump makes MFN deal with several biotechs, Bloomberg says

Aug 27, 2026 8:25am
pills drug costs money prices cash
Favicon Fierce Healthcare

Revised 340B Rebate Model Pilot Program moves forward

Jul 31, 2026 1:15pm
President Trump speaks in the Oval Office

Trump floats countdown to 200% tariff rate on imported generics

Jul 22, 2026 11:00am
EU pharma EU biopharma EU pharmaceutical industry European Union Euros

Germany approves controversial healthcare reform package

Jul 13, 2026 10:40am
Evolution step-up growth trajectory upward trajectory

How biosimilar developers are embracing next phase of US market

Jul 6, 2026 10:03am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings